Furthermore, any possible calcium fragments that can be disengaged with myocardial contraction will stay entrapped between the AML and mitral annular bed in our patients, even if they are the possible origin of emboli using Kurazumi's technique. Yoshikai et al. [5] have used an autologous pericardial patch to cover the partially decalcified (using a cavitron ultrasonic surgical aspirator) posterior mitral annular bed. In this region, the prosthetic mitral valve was fixed onto this pericardial patch. Therefore, both techniques [2, 5] were protective regarding embolic events, and also allowed us to implant an appropriatesized mitral prosthetic valve.
Finally, as we wrote [2] '… We do believe that our technique may sometimes be a technique of choice for MVR in a heavily calcified annulus'.
We have read with great interest the study by Pozzoli et al. [1] , which presented the in vivo assessment of pulmonary vein isolation (PVI) after open chest epicardial high-intensity focused ultrasound ablation (HIFU). The authors observed that up to 3 weeks after surgery, PVI was not achieved using the HIFU epicardial ablation system. Interestingly, this important finding was not correlated with the 100% absence of recurrence of atrial fibrillation (AF) at 1-year follow-up.
Traditionally, the first 3-month period after an ablation procedure is called the 'blanking' period. During this period, any assessment of efficacy is questionable because of the scarring and healing occurring in the heart. It is stated in the manuscript that the clinical success of AF ablation depends on persistent blocking of electrical conduction across the ablation lines. With bipolar radiofrequency (RF) clamps, the PV cuff is physically clamped and burned repeatedly in order to achieve 'acute' conduction block. A question for further reflection is: are we achieving block at that moment because of local tissue trauma and inflammation resulting from simultaneous crushing and burning of the PV cuff and is that block durable? Indeed, Benussi et al. [2] have shown previously that despite achieving block acutely with bipolar RF clamps, the veins often recover their ability to conduct (at 3 weeks in 15% of ablated patients).
It has been hypothesized that HIFU lesions may take time to scar in and mature. The mode of cell death for this energy source may differ from that of RF and thus may not always be instantaneous. Villamizar et al. [3] have demonstrated that HIFU ablation achieved 100% transmurality.
In our experience of using HIFU in 70 cases, we have observed thought-provoking clinical results. The freedom from recurrence of AF after ablation was 82% at 1 month, 90% at 1 year and 100% at 3 years in patients presenting with preoperative paroxysmal AF and undergoing concomitant open heart cardiac surgery with creation of only a box lesion and no additional ablation lines. Those patients were also free from anti-arrhythmic drugs at the time of follow-up. Those impressive results, however, were not observed in patients presenting preoperatively with permanent AF, showing a freedom from recurrence of AF of 42% at 1 month, 54% at 1 year and 62% at 3 years.
Our experience suggests that in order to achieve good clinical results using the HIFU ablation system it is important to use it in the right patients. In our experience, those patients presented with paroxysmal AF with normal or mildly dilated left atria (area <30 cm 2 ; volume <68 ml). We consider a simple box lesion sufficient to achieve a good postoperative clinical result. In patients with permanent AF, a more complex approach should be applied to treat an evolved histopathological condition of the atria.
We believe that the HIFU epicardial ablation system is a highperforming treatment modality creating transmural lesions in the left atrium and yielding good clinical results. Perhaps it is time to revisit the theory of acute conduction block!
